JARID1B expression was associated with lymph node metastases, FIGO stages, and histopathological differentiation, which could be helpful in understanding the progression and prognosis of patients with EOC. This evidence concerns the gene KDM5B and metastatic malignant neoplasm in the lymph nodes.